Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II clinical trial with RV-001 has been ...

TOKYO -- Japanese researchers from Keio University and elsewhere announced Thursday that they have begun a clinical trial on a gene therapy to restore light sensitivity in patients with retinitis ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.

Chris feels contestants need to be "tough" in order to survive the stresses of 'Strictly'. The comedy star is blind due to ...

Focused on the path ahead October ? December 2024 Net sales increased by 3 percent to SEK 7,729m (7,532).Gross profit increased by 2 percent to SEK 2,582m (2,526).EBITDA declined by 63 percent to SEK ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that the U.S. Patent and Trademark Office has issued a composition ...

A report from Zhongshan Daily & Zhongshan International Communications Center: In July 2024, the elderly health care vouchers of Hong Kong could be used in Zhongshan Chenxinghai Hospital. Zhongshan ...

The (AFB) is pleased to announce author Andrew Leland will be among those to receive the prestigious Helen Keller Achievement Award, which AFB will present during a special evening ceremony on April ...

Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...